Gilead Analyst Raises Target to $75 and 1 Stock Analysis to Notice Now
Prestige Brands Holdings Inc.’s (NYSE:PBH) changes have impressed Oppenheimer, and the firm thinks that the risk to the company presented by the return of Children’s Tylenol is overstated. The firm keeps its Outperform rating and a $18 target on the stock.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Gilead Sciences Inc. (NASDAQ:GILD) price target has been increased to $75 from $65 at Needham